High-Priced Drugs in Medicare Part D: Diagnosis and Potential Prescription
Drug pricing in the U.S. is a persistently vexing policy problem.
Drug pricing in the U.S. is a persistently vexing policy problem.
In these times of heated rhetoric about what various health care reforms can and cannot accomplish, both hopeful and doomsday stories abound.
Much of the risk adjustment literature has focused on how persons should be classified and given weights. It has given less attention to the amount of funds in the risk adjustment pool.
Risk-adjustment algorithms typically incorporate demographic and clinical variables to equalize compensation to insurers for enrollees who vary in expected cost, but including information about enroll
Increasing quality transparency is widely regarded as a strong mechanism for improving the alignment between patient choices and provider capabilities, and thus, is widely pursued by policymakers as a
Differences in patient characteristics across trials may bias efficacy estimates from indirect treatment comparisons.
Public Health Preparedness: Case Studies in Policy and Management provides detailed accounts of a range of public health emergencies.
Child stunting in India exceeds that in poorer regions like sub-Saharan Africa.
Organ-transplanted patients typically receive high amounts of immunosuppressive drugs (e.g., tacrolimus) as a mechanism to reduce their risk of organ rejection.
Telemedical Physician Triage (TPT) is an example of a Hierarchical Knowledge-Based Service System (HKBSS), in which a second level of decision agent (telemedical physician) renders a decision on cases
Get smart & reliable public policy insights right in your inbox.